However, there is no evidence so far that people with CF can stop or alter their current standard of care (antibiotics, physiotherapy, mucolytic agents, macrolides, etc.)while on CFTR modulators, especially since chronic infections are common in CF and may not disappear with current CFTR modulators. This evidence concerns the gene CFTR and cystic fibrosis.